News Feeds

Patient safety, news and press releases from EMA

• New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma, CHMP, 28/01/2022
• Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022, CHMP, 28/01/2022
• COVID-19: EMA recommends conditional marketing authorisation for Paxlovid, PRAC, 27/01/2022
• COVID-19: EMA recommends conditional marketing authorisation for Paxlovid, CHMP, 27/01/2022
• New EU rules for safe and high-quality medicines for animals become effective, , 28/01/2022
• Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched, , 25/01/2022
• Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca), CHMP, 24/01/2022
• Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022, CVMP, 21/01/2022
• International regulators’ recommendations on COVID-19 vaccines and the Omicron variant, , 21/01/2022
• COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy, PRAC, 18/01/2022

MedWatch Safety Alert RSS Feed

• Blaine Labs Issues Voluntary Nationwide Recall of RevitaDerm Wound Care Gel Due to Bacterial Contamination
• Philips Respironics Recalls Certain Trilogy EVO Ventilators for Potential Health Risks from PE-PUR Foam
• Update: Certain Philips Respironics Ventilators, BiPAP, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication
• Philips Respironics CPAP, BiPAP, and Ventilator Recalls: Frequently Asked Questions
• 2022 Medical Device Recalls
• Medtronic Inc. Recalls HawkOne Directional Atherectomy System Due to Risk of Tip Damage During Use
• Getinge USA Sales, LLC Recalls the Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems Due to a Risk of Harmful Chemical Exposure
• Sodium Citrate Blood Specimen Collection Tube Conservation Strategies – Letter to Health Care and Laboratory Personnel
• Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch
• UPDATE: Blood Specimen Collection Tube Conservation Strategies - Letter to Health Care and Laboratory Personnel